D.E. Shaw & Co
KYTH

D.E. Shaw & Co’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

D.E. Shaw & Co’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-327,904
Closed -$24.6M – 4134
2015
Q3 		$24.6M Buy
327,904
+87,038
+36% +$6.5M 0.04% 546
2015
Q2 		$18.1M Buy
240,866
+182,396
+312% +$9.77M 0.03% 671
2015
Q1 		$2.93M Buy
58,470
+39,785
+213% +$1.67M ﹤0.01% 1752
2014
Q4 		$648K Buy
+18,685
New +$652K ﹤0.01% 3140

D.E. Shaw & Co's KYTH Position: Q4 2015 in Review

D.E. Shaw & Co sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 327,904 shares — an estimated $24.6M sold.

D.E. Shaw & Co first reported a position in KYTH in Q4 2014 and held it in 4 quarters. The position peaked at $24.6M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • D.E. Shaw & Co reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 327,904 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $24.6M.
  • D.E. Shaw & Co first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2014 and held it in 4 quarters.
  • D.E. Shaw & Co's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $24.6M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.